データ・セキュリティとプライバシーの懸念が市場の成長を妨げる
膨大な量の生物学的・遺伝子学的データが生成・分析されることで、データのセキュリティとプライバシーに関する懸念が生じる。バイオインフォマティクス市場は、機密情報を保護し、厳しいデータ保護規則を遵守する上で問題に直面しています。
例えば、2023年3月、国立標準技術研究所のNational Cybersecurity Center of Excellenceは、遺伝子データのサイバーセキュリティとプライバシーに関する現行の規制、基準、管理は適切ではないとする草案を発表し、提案されているユースケースと保護について一般から意見を募集しています。このように、セキュリティ・リスクと懸念のために、厳格な規則と規制が施行されなければ、バイオインフォマティクス市場は予測期間中に没落する可能性があります。
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product & Services Type
3.2. Snippet by Application
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Nucleic Acid and Protein Sequencing
4.1.1.2. Utilization of AI and Machine Learning
4.1.2. Restraints
4.1.2.1. Data Security and Privacy Concerns
4.1.3. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product & Services Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services Type
7.1.2. Market Attractiveness Index, By Product & Services Type
7.2. Knowledge Management Tools*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bioinformatics Platforms
7.4. Bioinformatics Services
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Genomics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gene Engineering
8.4. Drug Development
8.5. Omics
8.6. Personalized Medicine
8.7. Other
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The U.K.
9.3.5.3. France
9.3.5.4. Spain
9.3.5.5. Italy
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japa
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Illumina Inc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Thermo Fischer Scientific
11.3. Qiagen NV
11.4. Agilent Technologies
11.5. PerkinElmer
11.6. Celera Corporation
11.7. Dassault Systèmes
11.8. Data4Cure
11.9. Geneva Bioinformatics SA
11.10. Lineage Cell Therapeutics
12. Appendix
12.1. About Us and Services
12.2. Contact Us
